India - Express Pharma

EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth

19th International Conference of Drug Regulatory Authorities commences in India

Govt bans 156 FDCs with immediate effect

DCGI waives off local trials for drugs approved in well-regulated markets

Navigating the IPR maze: India’s pharmaceutical challenge

Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy

Decoding Budget 2024-25: A lacklustre budget for pharma

Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0

Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari

Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond